Haemovigilance is defined by the International Haemovigilance Network as ‘a set of surveillance procedures covering the whole transfusion chain from the collection of blood and its components to the follow-up of recipients. It is intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products, and to prevent their occurrence or recurrence’. 

The Western Australian haemovigilance reporting system is a voluntary statewide activity to capture serious hospital transfusion adverse events. WA Haemovigilance reporting aligns with the National Safety and Quality Health Service Standard 7 on Blood and Blood Products (external site) which requires that:

  • health service organisations ensure that adverse events are included in their local incident management and investigation systems
  • health service organisations participate in haemovigilance activities conducted at state or national levels
  • the clinical workforce documents any adverse reactions to blood or blood products.

These criteria highlight the importance of conducting haemovigilance and promoting the safe management of blood and blood products.  Contributing WA data to national haemovigilance reporting also provides the opportunity to improve upon clinical practice and blood product safety.

WA Haemovigilance Toolkit:

These downloadable documents contain resources that will support and guide hospital staff in collecting haemovigilance data.

Further information

Georgina Low
Office of the Chief Medical Officer
2nd Floor, C Block
189 Royal Street
East Perth 6009

Phone: 9222 4370
Email: georgina.low@health.wa.gov.au

Produced by

WA Blood Management